Skip to main content

Advertisement

Experimental Hematology & Oncology accepted for inclusion in SCIE

We are delighted to announce that Experimental Hematology & Oncology has been accepted for inclusion in Science Citation Index Expanded (SCIE), a key database of Web of Science, published by Clarivate Analytics. Starting 2020, Experimental Hematology & Oncology will be published in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score, and Journal Impact Factor.

We would like to thank everyone for supporting Experimental Hematology & Oncology and contributing to this success. 

Featured article: Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin

Bullous hemorrhagic dermatosis (BHD) is a systemic side-effect of low molecular weight heparin, characterized by multiple intra-epidermal hemorrhages distant from the site of injection. There have been several small case series and literature reviews on BHD, but none have captured a complete set of reported patients. Here, Dr. Russo et al. sought to describe a case of BHD with late diagnosis and completely summarize the existing English and Spanish literature with searches of Pubmed, Scopus, Ovid Embase and Ovid Medline.

Aims and scope

Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.

Experimental Hematology & Oncology is the companion journal of Journal of Hematology & Oncology.

Articles

Most accessed articles RSS

View all articles

Editors-in-Chief

Kongming Wu, Tongji Medical College
Delong Liu, New York Medical College
Zihai Li, Medical University of South Carolina

Editor's quote

"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. Experimental Hematology & Oncology also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."

Delong Liu

Latest Tweets

Advertisement

Annual Journal Metrics

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here

Advertisement